Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000468789 | SCV000563711 | likely benign | Mitochondrial complex II deficiency, nuclear type 1; Paragangliomas 5 | 2024-01-28 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000569519 | SCV000674962 | likely benign | Hereditary cancer-predisposing syndrome | 2023-07-26 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genetic Services Laboratory, |
RCV001821384 | SCV002066324 | likely benign | not specified | 2021-08-17 | criteria provided, single submitter | clinical testing | |
Ce |
RCV004597809 | SCV005093534 | likely benign | not provided | 2024-07-01 | criteria provided, single submitter | clinical testing | SDHA: BP4, BP7 |